Doug Wall serves as managing partner of Volcano Capital, a multistrategy hedge fund and venture capital firm that invests in health-care companies across a variety of asset classes, including venture capital, public equities, and debt. Doug Wall began his career at a medical device company, Vital Signs, Inc., where he led investor relations and was involved in its $860 million sale to General Electric in 2008. He enhanced his knowledge of the field as an analyst at Outer Islands Capital, where he managed coverage of medical technology and life science tools. Doug Wall serves as a board member for eight medical device companies, including Circa Scientific, Mercator MedSystems, Roxwood Medical, Transaortic Medical, Visionsense, Apex Medical, and HydroCision. He also acts as board observer for five additional companies.